Virtually Assisted Home Rehabilitation After Acute Stroke-2
(VAST-rehab2)
1 other identifier
interventional
15
1 country
1
Brief Summary
The purpose of this study is to assess feasibility of a virtual rehabilitation program in stroke patients and to assess treatment effects, patient goal attainment with self-guided rehabilitation activities, barriers to and facilitators of telerehab, hospital readmission events, and social determinants of health
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable stroke
Started Mar 2023
Shorter than P25 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 27, 2023
CompletedFirst Posted
Study publicly available on registry
February 21, 2023
CompletedStudy Start
First participant enrolled
March 9, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 26, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 26, 2024
CompletedFebruary 23, 2024
February 1, 2024
11 months
January 27, 2023
February 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The experience of the participant measured by the participant experience surveys
end of study (about 10 weeks after baseline)
Number of participants that completed all scheduled visits.
end of study (about 10 weeks after baseline)
Secondary Outcomes (33)
Change in impact of stroke as assessed by the Stroke Impact Scale (SIS)
Baseline, end of intervention (about 5 weeks after baseline)
Change in quality of life as assessed by the Short Form (SF-12)health questionnaire
Baseline, end of intervention (about 5 weeks after baseline)
Change in cognitive impairment as assessed by the Montreal Cognitive Assessment (MoCA)
Baseline, end of intervention (about 5 weeks after baseline)
Change in depression as assessed by the Patient Health Questionnaire (PHQ8)
Baseline, end of intervention (about 5 weeks after baseline)
Change in disability as assessed by the Modified Rankin Scale (mRS)
Baseline, end of intervention (about 5 weeks after baseline)
- +28 more secondary outcomes
Study Arms (1)
Telerehabilitation (VAST 2)
EXPERIMENTALInterventions
The telehealth platform will be available by a web secure link accessible on a home computer or loaded on user friendly tablets that are customized for the patient's impairments. Telerehabilitation services will include 2 out of 3 disciplines: Occupational Therapy, Speech Therapy, Physical Therapy. All therapy interventions will be delivered by licensed therapists and will be based on patients' specific impairments and goals. Therapy intervention will be provided 3x/wk. for each of 2 disciplines. The intervention will be going on for 4 weeks which will total to 24 sessions. Self-management support with trained health coach will be integrated into 1 therapy session each week. An additional individual 30 minute session will occur with the health coach each week.
Eligibility Criteria
You may qualify if:
- Informed consent provided by the subject or legally authorized representative.
- Diagnosed with hemorrhagic or ischemic stroke
- Pre-stroke mRS is less than 3
- Qualifying Stroke Event must be confirmed by CT or MRI
- Recommended to participate in self-guided or in-person rehabilitation activities by a physician or rehabilitation therapist
- Must have sufficient cognitive and language abilities to comprehend verbal commands and to carry out the study assessments
- Able to access the internet
- Mild-moderate impairments in motor or cognitive function
You may not qualify if:
- History of neurological or other disease resulting in significant functional impairment (e.g. Parkinson's disease, motor neuron disease, moderate dementia, arthritis, contractures or fixed anatomical abnormality).
- Subjects with a severe comorbid disorder that has reasonable likelihood of limiting survival to less than 6 months.
- Any other conditions that, in the opinion of the investigators, would preclude safe and/or effective participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sean Savitz, MD
The University of Texas Health Science Center, Houston
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 27, 2023
First Posted
February 21, 2023
Study Start
March 9, 2023
Primary Completion
January 26, 2024
Study Completion
January 26, 2024
Last Updated
February 23, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share